<div id="readability-page-1"><p>Piper Sandler analyst Biren Amin maintained a Buy rating on Arcellx Inc today and set a price target of $115.00.</p><h3>Claim 50% Off TipRanks Premium and Invest with Confidence </h3><ul><li>Unlock  hedge-fund level data  and  powerful investing tools  designed to help you make smarter, sharper decisions  </li><li> Stay ahead of the market with  the latest news and analysis  so your portfolio is always positioned for maximum potential</li></ul> <p>According to TipRanks, Amin is a 4-star analyst with an average return of <span>6.8%</span> and a 46.69% success rate. Amin covers the Healthcare sector, focusing on stocks such as Nurix Therapeutics, Ocular Therapeutix, and BridgeBio Pharma.</p> <p>In addition to Piper Sandler, Arcellx Inc also received a Buy from Canaccord Genuity’s John Newman in a report issued today. However, on December 9, TR | OpenAI – 4o downgraded Arcellx Inc (NASDAQ: ACLX) to a Sell.</p></div>

ACLX

<p>Piper Sandler analyst Biren Amin maintained a Buy rating on Arcellx Inc with a $115 price target. Amin, a 4-star analyst, has a 6.8% average return and a 46.69% success rate. Canaccord Genuity also issued a Buy rating, while TR downgraded Arcellx to a Sell on December 9.</p>

Arcellx Inc (ACLX) Gets a Buy from Piper Sandler